Evidence map›Paper›PMID 42656820›Full record

ArticleBio-protocol2026

Efficient and Fast Site-Directed Mutagenesis via Partially or Completely Overlapping Primer Pairs.

Paulina Varela-Castillo, Arezousadat Razavi, Changsheng Zhao, Martin M Geng, Amitis Nour, Xiang-Jiao Yang

Abstract read
In one paragraph

Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paulina Varela-CastilloRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.
Arezousadat RazaviRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.
Changsheng ZhaoRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.
Martin M GengRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.
Amitis NourRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.
Xiang-Jiao YangRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Site-directed mutagenesis is an indispensable molecular biology tool, but traditional methods often suffer from extended reaction time, structural limitations, and variable success rates. This article details three optimized protocols: P3a (primer pairs with 3'-overhangs, version a), P3b, and QuickChange 2.0, which rely on two highly processive DNA polymerases (Platinum SuperFi II and Q5) to accelerate and standardize plasmid engineering. The P3a method utilizes partially complementary primer pairs with distinct 3'-overhangs, achieving ~100% efficiency and enabling seamless cassette mutagenesis (insertion, deletion, and replacement). Building on this, the P3b method introduces specific thermal cycling modifications and a pre-denaturation step to overcome structural barriers resulting from GC-rich sequences. QuickChange 2.0 applies these two advanced polymerases to completely complementary primer pairs, even though the average efficiency decreases to 50%-60%. Replacing Pfu with the highly processive DNA polymerases also reduces PCR time to approximately 2 h. Thus, these new methods are more efficient and rapid than classical QuickChange mutagenesis based on Pfu polymerase. Key features • P3a uses 3'-overhang primers and superior polymerases for near-perfect efficiency in routine point mutations and seamless cassette mutagenesis. • P3b adapts the 3'-overhang primer design with specialized thermal cycling to successfully overcome structural barriers in highly GC-rich templates. • The QC2 protocol leverages completely complementary primers for fast and reliable introduction of point mutations and small insertions or deletions.

Indexed as

Cas9Epigenetic regulatorGenome editingG-quadruplexPCRQuickChange methodSite-directed mutagenesis

Identifiers

PMID42656820
PMCPMC13507973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.